Strides Pharma Science Confirms Scheme of Demerger Effective Date for Arco Lab and Pivot Path
Strides Pharma Science Limited confirmed that the Scheme of Demerger involving Arco Lab Private Limited and Pivot Path Private Limited has become effective. The demerger, concerning the identified business of Arco Lab to Pivot Path, became effective from June 1, 2026.The Company stated that following the approval granted by the National Company Law Tribunal, Bengaluru Bench (NCLT), the scheme was finalized. This operational status was established after a certified copy of the NCLT Order approving the Scheme of Demerger was received on May 25, 2026.
The key details regarding the demerger include the following timeline and participants:
| Detail | Status/Date |
|---|---|
| Company Involved | Strides Pharma Science Limited |
| Demerger Entities | Arco Lab Private Limited and Pivot Path Private Limited |
| Regulatory Approval | NCLT, Bengaluru Bench |
| NCLT Order Received | May 25, 2026 |
| Scheme Effective Date | June 1, 2026 |
STAR Stock Price Movement
Strides Pharma Science Limited shares today slipped by 1.72% to settle at ₹1094.1. The stock saw a significant trading day, recording a total volume of 189,081 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.